CFLAR甲基化修改对肝脂代谢的调控影响

Chen Ye1, Wen Jiang1, Ting Hu1

  • 1National & Local Joint Engineering Research Center of High throughput Drug Screening Technology, Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, College of Health Science and Engineering, Hubei University, Wuhan 430062, China.

概括

氨基甲基转移酶1 (PRMT1) 通过甲基化CFLAR促进非酒精性脂肪性肝病 (NAFLD) 的脂质积累,导致其降解. 向PRMT1可能为NAFLD提供新的治疗策略.